Related Experiment Video
Updated: Jul 30, 2026
Fluorescence detection methods for microfluidic droplet platforms
Published on: December 10, 2011
Advancing Microfluidic Immunity Testing Systems: New Trends for Microbial Pathogen Detection
Yiran Wang1, Jingwei Chen1, Yule Zhang1
1Engineering Research Center of Optical Instrument and System, The Ministry of Education, Shanghai Key Laboratory of Modern Optical System, University of Shanghai for Science and Technology, Shanghai 200093, China.
Abstract:
Pathogenic microorganisms play a crucial role in the global disease burden due to their ability to cause various diseases and spread through multiple transmission routes. Immunity tests identify antigens related to these pathogens, thereby confirming past infections and monitoring the host's immune response. Traditional pathogen detection methods, including enzyme-linked immunosorbent assays (ELISAs) and chemiluminescent immunoassays (CLIAs), are often labor-intensive, slow, and reliant on sophisticated equipment and skilled personnel, which can be limiting in resource-poor settings. In contrast, the development of microfluidic technologies presents a promising alternative, offering automation, miniaturization, and cost efficiency. These advanced methods are poised to replace traditional assays by streamlining processes and enabling rapid, high-throughput immunity testing for pathogens. This review highlights the latest advancements in microfluidic systems designed for rapid and high-throughput immunity testing, incorporating immunosensors, single molecule arrays (Simoas), a lateral flow assay (LFA), and smartphone integration. It focuses on key pathogenic microorganisms such as SARS-CoV-2, influenza, and the ZIKA virus (ZIKV). Additionally, the review discusses the challenges, commercialization prospects, and future directions to advance microfluidic systems for infectious disease detection.
Insights
Microfluidic technologies offer rapid, automated immunity testing for pathogens like SARS-CoV-2, influenza, and ZIKV, overcoming limitations of traditional assays. These advanced systems promise efficient, high-throughput infectious disease detection, especially in resource-limited settings.
Area of Science:
- Biomedical Engineering
- Infectious Disease Diagnostics
- Microfluidics
Background:
- Pathogenic microorganisms contribute significantly to global disease burden.
- Traditional immunity tests (ELISAs, CLIAs) are slow, labor-intensive, and require specialized equipment.
- Limitations of traditional methods hinder effective infectious disease surveillance, particularly in resource-poor areas.
Purpose of the Study:
- To review advancements in microfluidic systems for rapid, high-throughput pathogen immunity testing.
- To highlight microfluidic applications for detecting SARS-CoV-2, influenza, and ZIKV.
- To discuss challenges and future directions for microfluidic infectious disease diagnostics.
Main Methods:
- Review of recent literature on microfluidic technologies for immunity testing.
- Focus on immunosensors, single molecule arrays (Simoas), lateral flow assays (LFAs), and smartphone integration.
- Analysis of microfluidic systems applied to specific pathogens like SARS-CoV-2, influenza, and ZIKV.
Main Results:
- Microfluidic systems enable automation, miniaturization, and cost-effective pathogen detection.
- Integration of technologies like Simoas and LFAs enhances speed and throughput.
- Smartphone integration offers potential for point-of-care diagnostics.
Conclusions:
- Microfluidics represent a significant advancement over traditional immunity assays.
- These technologies are crucial for improving infectious disease detection and surveillance globally.
- Further research and commercialization are needed to fully realize the potential of microfluidic diagnostics.
Related Concept Videos
01:17Microbial Biosensors
01:25Rapid Identification of Pathogens
01:24Automated Microbial Diagnostics